EROAD's PBT loss widened 37.3% even as tax effects narrowed NPAT 90%

The gap is explained by the effective tax rate swinging to 95.7% from 41.2%, a tax-line effect rather than an operating one.

Revenue rose 4.1% to $182.0m from $174.9m reported, but FY23 included a one-off Coretex acquisition accounting adjustment; normalised FY23 revenue was $165.3m, so the reported comparison is not fully like-for-like across the two periods.

EBITDA rose to $53.3m from $45.2m. Operating cash flow jumped to $52.9m from $24.1m, aided by a $25.4m swing in working capital (from +$22.5m to -$2.9m). Gross borrowings nearly halved to $36.6m from $70.6m, and cash rose to $14.5m from $8.1m.

PBT is the cleaner read here: a widening pre-tax loss (down 37.3%) sits behind a narrower reported NPAT loss (up 90.0%), driven almost entirely by the tax line. This matters because a reader looking only at the narrower headline loss could conclude trading improved more than it did at the pre-tax level.

Cash conversion improved but partly on working-capital timing. OCF-to-EBITDA rose to 99.2% from 53.3%, helped by a $25.4m working-capital swing and receivable days falling to 41.5 from 46.98. Contract liabilities of $23.6m point to growing customer prepayments, which is a normal SaaS quality signal, but the scale of the working-capital turn means part of this cash improvement is timing-related rather than structural margin gain.

Revenue growth is not clean like-for-like. The reported 4.1% growth sits against a prior period that management itself normalises to $165.3m, implying materially stronger underlying growth. Investors should treat the headline growth figure with caution given the acquisition-related distortion flagged across the current, prior and interim periods.

Second-half shape data shows H1 accounted for roughly 48.8% of full-year revenue and 48% of EBITDA, but NPAT was disproportionately weighted to H2, implying an H1 loss of roughly $1.0m swinging to an implied H2 profit near $0.9m.

That second-half swing is suggestive of an improving trajectory, but because the FY24 NPAT improvement was itself driven by a favourable tax outcome rather than pre-tax profitability, the more meaningful test for FY25 is whether the pre-tax loss trend reverses, not whether NPAT alone continues to narrow.

However, the $25.4m working-capital swing means a meaningful share of the OCF jump is timing-driven and may not repeat at the same scale next year.

Capex rose to $32.2m from $27.5m, which complicates the cash picture. On a simple OCF-less-capex basis this implies roughly a $20.7m cash build, materially different from the $1.3m positive free-cash-flow-to-the-firm figure management cites in its release commentary (against a $29.9m outflow in FY23) — the reconciling items between these two views are not disclosed here. Deleveraging (borrowings down to $36.6m from $70.6m alongside equity up to $303.0m from $248.8m) also raises the question of whether debt reduction was funded from operations or from external capital.

This briefing cannot assess FY25 guidance credibility, ARR, retention or customer-concentration metrics, as none were disclosed in the extracted release materials.